Article Information
History
- February 21, 2024.
Article Versions
- Version 1 (December 20, 2022 - 09:55).
- Version 2 (June 15, 2023 - 15:13).
- Version 3 (September 8, 2023 - 13:37).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yufeng Song1,
- Regan Myers1,
- Frances Mehl1,
- Lila Murphy1,2,
- Bailey Brooks1,2,
- Jeffrey M. Wilson3,
- Alexandra Kadl4,5,
- Judith Woodfolk4 and
- Steven L. Zeichner1,6,*
- 1Department of Pediatrics, University of Virginia
- 2College of Arts and Sciences, University of Virginia
- 3Division of Allergy and Clinical Immunology, Department of Medicine, University of Virginia
- 4Department of Medicine, University of Virginia
- 5Department of Pharmacology, University of Virginia
- 6Department of Microbiology, Immunology, and Cancer Biology, University of Virginia
- ↵*Correspondence: zeichner{at}virginia.edu
Posted February 21, 2024.
ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients
